These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24107764)

  • 1. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.
    Spencer TJ; Brown A; Seidman LJ; Valera EM; Makris N; Lomedico A; Faraone SV; Biederman J
    J Clin Psychiatry; 2013 Sep; 74(9):902-17. PubMed ID: 24107764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Rubia K; Alegria AA; Cubillo AI; Smith AB; Brammer MJ; Radua J
    Biol Psychiatry; 2014 Oct; 76(8):616-28. PubMed ID: 24314347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.
    Czerniak SM; Sikoglu EM; King JA; Kennedy DN; Mick E; Frazier J; Moore CM
    Harv Rev Psychiatry; 2013; 21(3):151-62. PubMed ID: 23660970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD.
    Norman LJ; Sudre G; Bouyssi-Kobar M; Sharp W; Shaw P
    Am J Psychiatry; 2021 Aug; 178(8):744-751. PubMed ID: 34086483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
    Stuhec M; Lukić P; Locatelli I
    Ann Pharmacother; 2019 Feb; 53(2):121-133. PubMed ID: 30117329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].
    Huber M; Kirchler E; Niederhofer H; Gruber L
    Fortschr Neurol Psychiatr; 2007 May; 75(5):275-84. PubMed ID: 17443438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
    Yoo JH; Kim D; Choi J; Jeong B
    Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder in childhood epilepsy: a neuropsychological and functional imaging study.
    Bechtel N; Kobel M; Penner IK; Specht K; Klarhöfer M; Scheffler K; Opwis K; Schmitt-Mechelke T; Capone A; Weber P
    Epilepsia; 2012 Feb; 53(2):325-33. PubMed ID: 22242637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain abnormalities in attention-deficit hyperactivity disorder: a review.
    Rubia K; Alegría AA; Brinson H
    Rev Neurol; 2014 Feb; 58 Suppl 1():S3-16. PubMed ID: 25252664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
    Weisler RH; Pandina GJ; Daly EJ; Cooper K; Gassmann-Mayer C;
    CNS Drugs; 2012 May; 26(5):421-34. PubMed ID: 22519922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.